Open AccessA Tertiary Cardiology Unit Perspective for Carotid Lesions: Which Lesion and When Intervention
Author(s) -
Emre Özdemir,
Muhammet Mücahit Tiryaki,
Nihan Kahya Eren,
Cem Nazlı,
Mehmet Tokaç
Publication year - 2020
Publication title -
i̇zmir tepecik eğitim hastanesi dergisi
Language(s) - English
Resource type - Journals
eISSN - 1305-7146
pISSN - 1305-7073
DOI - 10.5222/terh.2020.71677
Subject(s) - medicine , carotid endarterectomy , stroke (engine) , common carotid artery , mortality rate , etiology , angiography , carotid artery disease , comorbidity , population , cardiology , coronary artery disease , radiology , surgery , carotid arteries , mechanical engineering , environmental health , engineering
Stroke is one of the most common cause of mortality and morbidity all over the world, while atherosclerosis is the most common cause of its etiology. For this patients carotid endarterectomy (CEA) and carotid stenting (CAS) are two treatment modalities. In our study, carotid angiography in a tertiary center screened and treatment experiences, methods will present. METHODS: Carotid angiography performed in our hospital between June 2006 and 2018 in a single tertiary cardiology clinic was retrospectively screened and patients were included in the study including CAS, CAE and medical follow-up. The patient's clinical features and procedure-related data were obtained by scanning the patient files. RESULTS: A total of 905 carotid angiography were screened. Critical carotid artery lesions were detected in 476 patients. 49 patients were classified as CAS, 192 patients as CEA, and 235 as medical group. The mean age of the included patients was 66.08±10.53 and the patient population was 74.2% male. The most common comorbidity was coronary artery disease (81.6%) and arterial hypertension (63.3%). The most common symptom was stroke (73.3%). In the CAS group, the rate of stroke was 6.1% in the follow-up period, the rate of stroke in the medical follow-up group was 5.5%, and in the CEA group, the stroke rate was 3.6%. There was a 3.1% mortality in the CEA group. The procedure was completed without any complication in all CAS patients. The mean follow-up period was 1034 days. DISCUSSION AND CONCLUSION: Although CEA is still a class 1 indication despite the improvements in stent and protection devices, CAS can successfully perform in our center as well as in experienced centers.